ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Sigma-1 Receptor Agonists Are Protective in a Rat Model of Kidney Transplantation

    A. Hosszu1, T. Lakat1, A. Toth1, J. Hodrea1, L. Wagner2, A. J. Szabo1, A. Fekete1

    11st Department of Pediatrics, Semmelweis University, Budapest, Hungary, 2Department of Transplantation and Surgery, Semmelweis University, Budapest, Hungary

    *Purpose: Kidney transplantation (Tx) is associated with better long-term outcomes and quality of life compared to dialysis, but the shortage in donor organs is serious…
  • 2022 American Transplant Congress

    Neuropilin-2 is a Novel Checkpoint Inhibitor That is Required for Long-Term Allograft Survival

    J. Wedel, S. Kong, K. Liu, N. Kochupurakkal, D. Bala, D. Bielenberg, H. Nakayama, D. M. Briscoe

    Boston Children's Hospital, Boston, MA

    *Purpose: We have previously reported that Neuropilin (NRP) 2-associated signaling events modulate PI3K/mTOR/Akt activity in several human cell lines. While intrinsic NRP1 activity has been…
  • 2022 American Transplant Congress

    Personalized Medicine Using Next-Generation Sequence for Kidney Transplant Recipients

    J. Sanchez-Garcia, D. Morris, E. Darling, M. Dantis-Tan, J. Olson, K. Gaid, A. Raza, S. Anand

    Intermountain Medical Center, Murray, UT

    *Purpose: Tissue diagnosis definitely drives therapeutic and prognostic decisions amongst patients with chronic kidney disease (CKD). However, patients with CKD often present late in the…
  • 2022 American Transplant Congress

    Vitamin D Deficiency in Liver Transplant Recipients

    V. Subramanian1, T. Lippert2, J. Buggs1, N. Kemmer1, K. Dhanireddy1

    1Transplant Institute, Tampa General Hospital, Tampa, FL, 2University of South Florida, Tampa, FL

    *Purpose: Patients with chronic liver disease are at risk of nutritional deficiency. The goal of this study was to determine the prevalence of vitamin D…
  • 2022 American Transplant Congress

    Optimal Dose of Anti-Thymocyte Globulin to Improve Allograft and Patient Survival After Kidney Transplantation: Analysis from Korean Organ Transplantation Registry Data

    Y. Shim, H. Kwon, Y. Kim, H. Kwon, J. Jung, Y. Ko, S. Lim, S. Shin

    Surgery, Asan Medical Center, Seoul, Seoul, Korea, Republic of

    *Purpose: The optimal dose of anti-thymocyte globulin (ATG) as an induction regimen in Asian kidney recipients is unclear.*Methods: Using Korean Organ Transplantation Registry database, we…
  • 2022 American Transplant Congress

    Early Impact of the Mission Act on Utilization of Veterans Affairs Transplant Centers

    J. C. Walker1, C. Roumie2, I. D. Feurer3, R. Forbes4

    1General Surgery, Vanderbilt University Medical Center (VUMC), Nashville, TN, 2Internal Medicine, VUMC, Nashville, TN, 3Surgery and Biostatistics, VUMC, Nashville, TN, 4VUMC, Nashville, TN

    *Purpose: The Veterans Affairs (VA) Maintaining Systems and Strengthening Integrated Outside Networks (MISSION) Act of 2018 was implemented in 2019 to increase veteran access to…
  • 2022 American Transplant Congress

    Infiltrating CD8+ Cytotoxic T Cells Are Converted to a Regulatory Phenotype in Accepted Kidney Allografts

    T. Yokose1, E. S. Szuter1, M. T. Guinn1, J. Ge2, I. Rosales3, M. Ford4, P. S. Russell1, A. G. Cuenca2, J. C. Madsen1, R. B. Colvin1, A. Alessandrini1

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Boston Children's Hospital, Boston, MA, 3Department of Pathology, Massachusetts General Hospital, Boston, MA, 4Department of Surgery, Emory University, Atlanta, GA

    *Purpose: Mouse kidney allografts are spontaneously accepted in select, fully-mismatched donor-recipient strain combinations (i.e. DBA/2J to C57BL/6 (B6)) without any immunosuppressive drug treatment. We have…
  • 2022 American Transplant Congress

    Donor-Derived Duodenal Adenocarcinoma of a Bladder-Drained Pancreas Allograft

    D. Isaacson1, J. Steggerda1, Y. Xue1, G. B. Auffenberg2, N. N. Katariya3

    1Northwestern University, Chicago, IL, 2Urology of St. Louis, St. Louis, MO, 3Mayo Clinic, Phoenix, AZ

    *Purpose: Donor-derived malignancies are rare but frequently present with aggressive pathology and high mortality rates [PMID 32627325]. The urologic literature demonstrates an increased risk of…
  • 2022 American Transplant Congress

    Characteristics and Outcomes of Patients Admitted for Acute Alcoholic Hepatitis Before and During the COVID-19 Pandemic

    M. S. Anderson1, S. Uttal2, M. Bertha3, K. Jencks2, H. Asefah2, A. Gustafson3, K. N. Truitt3, P. Maddur3, J. Mellinger2

    1Surgery, Michigan Medicine, Ann Arbor, MI, 2Internal Medicine, Michigan Medicine, Ann Arbor, MI, 3Internal Medicine, Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Despite known increases in alcohol use, changes in alcohol-associated liver disease rates during COVID-19 have not been well characterized. We compared the incidence and…
  • 2022 American Transplant Congress

    Monitoring Efficacy of Tocilizumab Treatment for Chronic Antibody Mediated Rejection (cAMR) in Kidney Transplants Using Donor-Derived Cell-Free DNA (dd-cf-DNA)

    J. Tang1, A. Vo1, E. Huang1, X. Zhang2, N. Ammerman1, A. Peng1, R. Najjar1, S. Sethi1, K. Lim1, M. Gillespie1, N. Badash1, S. Jordan1

    1Comprehensive Transplant Center, Cedars Sinai Medical Ctr, Los Angeles, CA, 2HLA Laboratory, Cedars Sinai Medical Ctr, Los Angeles, CA

    *Purpose: IL-6/IL-6R have emerged as important targets for treating cAMR. Recent data show that long-term treatment can stabilize eGFR, reduce DSAs and result in a…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 190
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences